Showing results (2201-2210 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|May 13, 2017
People's Understanding of Verbal Risk Descriptors in Patient Information Leaflets: A Cross-Sectional National Survey of 18- to 65-Year-Olds in EnglandRebecca K Webster, John Weinman, G James RubinDrug Safety|June 30, 2018
Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription DatabaseLeticia Ortiz de Landaluce, Pere Carbonell, Carmen Asensio, et al.Drug Safety|August 2, 2018
Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting SystemJames R Rogers, Ameet Sarpatwari, Rishi J Desai, et al.Drug Safety|September 1, 2018
Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with AdalimumabKaren Smith, Su Golder, Abeed Sarker, et al.Drug Safety|February 18, 2010
The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysisAnne J Leendertse, Djurre Visser, Antoine C G Egberts, et al.Drug Safety|September 2, 2016
Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and NeedsCristiano Matos, Linda Härmark, Florence van HunselDrug Safety|September 11, 2016
Vaccine Case-Population: A New Method for Vaccine Safety SurveillanceHélène Théophile, Nicholas Moore, Philip Robinson, et al.Drug Safety|April 26, 2017
Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General PracticeS Jill Stocks, Evangelos Kontopantelis, Roger T Webb, et al.Drug Safety|December 17, 2009
Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studiesRyan Banach, Radinka Boskovic, Thomas Einarson, et al.Drug Safety|April 9, 2018
The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up StudyHelen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza, et al.Pageof 309